AI News on AI Brief | AI-101.tech

Meta Raises Quest 3 and Quest 3S Prices Due to RAM Shortage

Thu, 16 Apr 2026 00:00:00 +0000

Meta is raising prices on its Quest 3 and Quest 3S VR headsets effective April 19, 2026, with increases ranging from $50 to $100 per model. The culprit is a global surge in memory chip costs that has been hammering consumer electronics manufacturers across the board.

How Much Are Quest Prices Going Up?

Starting April 19, every Quest model gets a price bump. The entry-level Meta Quest 3S (128GB) climbs from $299.99 to $349.99 — a $50 increase. The **Meta Quest 3S (256GB)** follows the same trajectory, moving from $399.99 to $449.99. The flagship **Meta Quest 3** sees the steepest jump: a full $100 increase takes it from $499.99 to $599.99.

Vercel Signals IPO: AI Agents Drive 3.4x Revenue Growth

Tue, 14 Apr 2026 00:00:00 +0000

When Will Vercel Go Public? What the Numbers Say

When asked about an IPO at the 2026 HumanX conference, Vercel CEO Guillermo Rauch gave a telling answer: “The company is ready, and it gets better every day.” No timeline, but a clear forward signal.

The financial trajectory is impressive:

Period	ARR	Source
Early 2024	$100M	The Information
February 2026	$340M	Forbes
Growth	3.4x	~2 years

The last known valuation came in September 2024, when Vercel raised $300M in a Series F led by Accel, reaching a **$9.2B** valuation.

Anthropic Refuses to Build Weapons for the Pentagon — and the UK Reaches Out Instead

Tue, 07 Apr 2026 00:00:00 +0000

AI companies that draw lines have become a problem in the U.S. and an asset in the UK.

On April 7, Artificial Intelligence News reported on Anthropic’s negotiations with the UK government for expansion. The core of the story isn’t diplomatic maneuvering — it’s about a company being punished by its home country for standing on principle, and being proactively courted by another G7 nation as a result.

The Pentagon’s Ultimatum

The story starts in late February. U.S. Defense Secretary Pete Hegseth gave Anthropic CEO Dario Amodei a clear ultimatum: remove Claude’s safety restrictions on fully autonomous weapons and large-scale domestic surveillance, or face consequences.

Anthropic Spends $400M to Acquire Biotech AI Startup: Claude Formally Enters Drug Discovery

Sun, 05 Apr 2026 00:00:00 +0000

AI giants are starting to acquire biotech companies. On April 3, it emerged that Anthropic used approximately $400M in stock to acquire a stealth-mode AI biotech startup called Coefficient Bio.

The news spread beyond tech circles into biotech as well.

What Was Acquired

Coefficient Bio is not an ordinary startup. Founders Samuel Stanton and Nathan C. Frey both came from Genentech’s Presptive Design team — one of the world’s top computational drug design labs. They left eight months ago with a clear mission: use AI to accelerate drug discovery.